SDF for the Management of Dental Caries in Children in Primary Dental Care: Protocol for a Feasibility Study

A Feasibility Study to Determine Whether a Randomised Controlled Trial of Silver Diamine Fluoride Compared to Usual Care for the Management of Caries in Children's Primary Teeth is Feasible in UK Primary Dental Care

Dental caries remains a significant health problem in England, effecting 11% of 3-year-olds and 23% of 5-year- olds. Children with dental caries suffer pain, infection and poor oral health-related quality of life. There are different approaches for the management of childhood dental caries but it remains the most common reason for a hospital admission in the UK for children aged 5-9 years, costing the NHS £50 million in 2015-2016. While current approaches have been extensively investigated, their ability to: 1) control pain and infection; 2) prevent hospital admissions, and 3) be implemented within the current NHS contractual arrangements, remains unsatisfactory. Silver diamine fluoride (SDF) is an alternative and non-invasive approach that is applied topically (simple to manage for children) and has proven efficacy in arresting caries progression in primary teeth, principally from studies conducted outside Europe. Its use in primary dental care practice in the UK is limited despite acknowledged need.

However, the clinical and cost effectiveness of SDF has not been compared to usual care in the UK, so it is unknown which treatment is more effective. Before a pragmatic randomised controlled trial (RCT) can be conducted into the clinical and cost effectiveness of SDF compared to usual care, there are several uncertainties related to recruitment, retention and fidelity that require investigation in a feasibility study.

Research Question Is a randomised controlled trial (RCT) to compare the effectiveness of silver diamine fluoride (SDF) to usual care for the treatment of caries in children's primary teeth feasible in UK primary dental care? Aim The overall aim is to establish whether conducting a RCT to compare SDF to usual care for the treatment of caries in children's primary teeth is feasible.

Methods This mixed-method study is a feasibility study with an embedded process evaluation, to compare SDF with usual treatment in primary dental care in the UK. It will be individually randomised, with at least eight dentists, each in a different dental practice and a sample size of 80 participants. There will be ten participants per dentist and equal arm allocation. Follow-up will be for one year. The study will inform whether an RCT is feasible by resolving several key uncertainties. Acceptability and implementation of SDF and the research processes will be explored. Patient and Public Involvement and Engagement (PPIE) representatives will be involved throughout, further informing design including recruitment/retention strategies, participant documentation, analysis, engagement and dissemination.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children aged 2-6 years
  • Cavitated dentinal caries in any primary tooth
  • No carious involvement of the tooth pulp
  • No dental infection secondary to a non-vital tooth
  • Parent/carer able to complete consent forms (with the support of an interpreter if necessary)

Exclusion Criteria:

  • Allergy to any treatment component
  • Caries effecting the pulp
  • Infection secondary to a non-vital tooth
  • Conditions requiring special considerations for the child's dental management where randomisation would not be appropriate for example a medical history including cardiac defects, oncology, hereditary bleeding, or being immunocompromised.
  • Dental anomalies effecting the carious teeth involved: amelogenesis imperfecta, dentinogenesis imperfecta, molar incisor hypomineralisation, abnormal morphology such as double teeth.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Silver Diamine Fluoride
SDF treatment for caries in the primary teeth of children included
silver diamine fluoride - maximum 1 drop to be applied per visit (manufacturer advises this would treat up to 5 teeth)
Active Comparator: Usual Care
Usual care determined by child's dentist for caries in their primary teeth
Usual restorative or preventative care determined by the child's dentist - for examples fillings or crowns

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Data quality of candidate primary outcome measures - ICDAS
Time Frame: 18 months
• International Caries Detection and Assessment System (ICDAS) - by measuring percentage of completion and data quality
18 months
Data quality of candidate primary outcome measure - pain and infection including PUFA
Time Frame: 18 months
Occurrence or report of pain or infection and Pulpal involvement, Ulceration, Fistula, Abscess (PUFA) index by measuring percentage of completion and data quality
18 months
Data quality of candidate secondary outcome measure; referral to secondary care
Time Frame: 18 months
Referral to secondary care; measuring percentage of completion and data quality
18 months
Data quality of candidate secondary outcome measure; Completion course of treatment
Time Frame: 18 months
Completion course of treatment; measuring percentage of completion and data
18 months
Data quality of candidate secondary outcome measure; number of appointments taken for completion of a course of treatment
Time Frame: 18 months
The number of appointments taken for completion of a course of treatment; measuring percentage of completion and data quality
18 months
Data quality of secondary outcome measure; Adherence to intervention protocol or usual care guidelines.
Time Frame: 18 months
Adherence to intervention protocol or usual care guidelines. ; measuring percentage of completion and data quality
18 months
Data quality of candidate secondary outcome measure; Adverse effect(s).
Time Frame: 18 months
Adverse effect(s). ; measuring percentage of completion and data quality
18 months
Data quality of candidate secondary outcome measure; Appointment length
Time Frame: 18 months
Appointment length; measuring percentage of completion and data quality
18 months
Data quality of candidate secondary outcome measure; • number of units of dental activity claimed
Time Frame: 18 months
Number of units of dental activity claimed; measuring percentage of completion and data quality
18 months
Data quality of candidate secondary outcome measure; child and parental/carer reported experience of treatment
Time Frame: 18 months
Child and parental/carer reported experience of treatment. measuring percentage of completion and data quality
18 months
Data quality of candidate secondary outcome measure; Parental/carer reported oral health-related quality of life; P-CPQ16
Time Frame: 18 months
Parental/carer reported oral health-related quality of life; measuring percentage of completion and data quality
18 months
Variability of primary outcome measure; ICDAS or pain and infection
Time Frame: 18 months

This will be calculated once the specific measure has been chosen based on completion rates and data quality, and discussion with the study panel.

Calculation of the variability of the primary outcome measure that is ultimately chosen for a trial should it be deemed feasible.

18 months
recruitment, randomisation and retention rates of child participants
Time Frame: 18 months
Percentage rates of recruitment, randomisation and retention of child participants
18 months
recruitment and retention rates of dental professionals
Time Frame: 18 months
Percentage rates of recruitment and retention of dental professionals
18 months
rate of dentists' adherence to the study protocol (treatment allocation)
Time Frame: 18 months
Percentage of dentists which adhered to the randomisation determined treatment choice for the child
18 months
Data quality and percentage completion rates of cost effectiveness data; cost data completed in case report forms by dental professional
Time Frame: 18 months
Data quality and percentage completion rates of cost effectiveness data; cost data completed in case report forms (time of appointments, treatment carried out, number of UDAs claimed) by dental professional
18 months
Data quality of cost effectiveness data; parental questionnaires
Time Frame: 18 months
Data quality and percentage completion rates of cost effectiveness data; cost questionnaires completed by parents
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 22, 2023

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

February 28, 2025

Study Registration Dates

First Submitted

June 15, 2023

First Submitted That Met QC Criteria

October 13, 2023

First Posted (Actual)

October 23, 2023

Study Record Updates

Last Update Posted (Actual)

October 23, 2023

Last Update Submitted That Met QC Criteria

October 13, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries in Children

Clinical Trials on Silver diamine fluoride

Subscribe